-
JNNP: Late-oncological vitamin B2 transport protein deficiency is associated with various causes of motor neuropathy
Time of Update: 2020-11-06
studies have shown that RTDs have been linked in recent years to brown Vialetto Van Laere (BVVL) syndrome, a genetic disorder associated with motor neuropathy (MN) and deafness.
-
Alzheimer's disease in old age may be the result of young age
Time of Update: 2020-11-06
, obese people are 2.5 times more likely to develop cognitive impairment in later life than those with a normal BMI in early adulthood, according to the study.
-
JAMA Neurol: Prognostication and treatment of patients with micro-bleeding after stroke
Time of Update: 2020-11-06
patients aged 50 or over who had neuroimaging-proven ESUS between 7 and 6 months before screening reported micro-bleeding in baseline clinical magnetic resonance imaging and were randomly received daily with 15 mg of devasalban or 100 mg of aspirin.
study found an increased risk of relapsed stroke, isomorrhagic stroke, cerebral hemorrhage and mortality in patients with micro-hemorrhage.
-
Nature: Still watching the computer while playing with your cell phone? Be careful of memory loss
Time of Update: 2020-11-06
Using test-to-trial retrieval data, the researchers found that attention from strong-straight errors measured by rear α power and pupil diameter was associated with reduced nerve signals in target coding and memory, as well as behavioral forgetting.
-
Lancet Neurology: 1 case of SARS-CoV-2 infection suspected to cause Parkinson's disease
Time of Update: 2020-11-06
nasopharyngeal swab on the day of his hospitalization, he was found to be positive for SARS-CoV-2, with a full blood count and cRP testing normal, via real-time RT-PCR testing.
-
Sci Adv: The Tulip Tai team at Huashan Hospital found new targets for the prevention and treatment of neurodegenerative diseases
Time of Update: 2020-11-06
Based on clinical research, bioinficial analysis, and basic experiments, this study found for the first time that the new gene FAM171A2 is a key regulatory gene for the important protein particle protein prelude (progranulin, PGRN) associated with the onset of neurodegenerative diseases, and is a risk gene for neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and frontal lobe dementia (FTLD).
-
Lancet Neurol: Effects of high-dose biotin on disability progression in patients with advanced multiple sclerosis
Time of Update: 2020-11-06
Studies have found that high doses of drug-grade biotin (vitamin H, MD1003) may boost neuron and less protrusive glial cell energy and improve cell function, repair or survival. MS-SPI study found th
-
Slow disease prevention and control occurs in every four people! This disease is more important in prevention!
Time of Update: 2020-11-06
Up to 90 per cent of strokes can be prevented by addressing risk factors such as high blood pressure, poor eating habits, smoking and physical inercilability, while also helping to prevent and reduce health and loss of life from chronic diseases such as cardiovascular disease, cancer and diabetes.
-
Lancet Neurology: 1, 2, 3 and 6 spinal cord microcephaly disorder risk individuals to explicit co-assistance disorder (RISCA): a longitudinal cohort study
Time of Update: 2020-11-06
Our goal is to study the sensitivity of obvious health mutation carriers associated with SCA1, SCA2, SCA3, and SCA6 to co-dysfunction and to detect changes in these individuals by clinical and functional indicators.
-
Lancet Neurology: The safety, tolerance and effectiveness of oral Atogepant to prevent seizure migraines in adults: a double-blind, randomized phase 2b/3 trial
Time of Update: 2020-11-06
this paper aims to study the safety, toerability and efficacy of preventive treatment of migraines in Atogepant oral doses.
, the safety and efficacy results of the 2b/3 double-blind, placebo-controlled trial supported the initial efficacy and tolerance of taking Atogepant daily to prevent migraines.
-
The first Korean botulinum toxin product, Lotte, was approved in China
Time of Update: 2020-11-06
Approved for listing by the State Drug Administration, this is the fourth pharmaceutical company approved in China after U.S. drug companies Eljian, Lanzhou Institute of Biological Products and France's Ipsum, and the first of its kind in South Korea, which is expected to start selling in Chinese mainland within the year.
-
Sleep at night love to dream, sleep is equal to not sleep? Chinese medicine says to explain "many dreams" and solve the trouble
Time of Update: 2020-11-06
Chinese medicine five theology explains "many dreams" according to the theory of Chinese medicine, multi-dream is the human lung yin and yang blood loss and disorder caused by symptoms, and the human body's five gods have a full relationship, as long as there are irreconculable situations in these aspects, then it will lead to the emergence of multiple dreams.
-
Cell: A new target for brain metastasis immunotherapy, Zhang Siyuan's team revealed the regulatory role and mechanism of myelin cells in the central nervous system for brain metastasis
Time of Update: 2020-11-06
In terms of profile, this study, using a unique genetically engineered mouse model, clever experimental design, combined with clinical patient data and high-volume, multi-dimensional single-cell analysis (Figure 4), reveals that the central nervous system's own myelin cell CNS-myeloids can promote the development of brain metastasis through the specific immunosuppressive microenvironment of the genotypturing factor Cxcl10 signal, which fully illustrates the important regulatory role of tissue immunomic environment in the development process of tumor metastasis.
-
JAHA: Analysis of risk factors for stroke and its subtypes in China
Time of Update: 2020-11-06
, however, there are few queue studies to assess the socio-economic factors appropriate to the traditional risk factors of stroke and its subtypes in China.
, the study identifies socio-economic factors that complement traditional stroke and its subtype risk factors, thus reducing the stroke burden in a targeted way.
-
NMPA approves Phase III clinical trials of 18F-APN-1607 Tau PET imaging tracer for dementia
Time of Update: 2020-11-06
APRINOIA Therapeutics announced today that China's State Drug Administration (NMPA) has approved the launch of Phase III clinical trials to evaluate APRINOIA's positive electron emission fault scanning (PET) imaging tracer 18F-APN-1607, which targets abnormal tau protein aggregations in the brains of patients with cognitive impairment.
-
Can The Trends Cogn Sci machine change our minds?
Time of Update: 2020-11-04
to explore the potential challenges associated with adaptation, Suyi Zhang and colleagues designed experiments that conceptually mimic an algorithm that learns to optimize the parameters of pain-stimulating treatment.
-
Brain: The commonly used diabetes drug Essena peptide may be expected to help prevent or treat Parkinson's disease
Time of Update: 2020-11-04
3, 2020 // -- In a recent study published in the international journal Brain, scientists from University College London and others found that drugs to treat type 2 diabetes may reduce the risk of Parkinson's disease in patients.
-
Alzheimer's and Dementia: The relationship between baseline amyloid proteins and neurofiber tau deposition in β-age Down syndrome (NiAD).
Time of Update: 2020-11-04
recently, the emergence of positive electron emission fault scanning (PET) ligations for A beta and tau, such as piB3, and AV-14514, allows us to examine the relationship between cognition and AD pathophysiology in the body.
-
Why are more and more young people suffering from stroke? Doctor: There are 3 "differences" in the body, send to the doctor
Time of Update: 2020-11-04
" said earlier that many young stroke patients are because of lack of exercise, like to stay at home, long time low head to play mobile phone brush circle of friends, chasing drama, playing games, leading to illness.
-
Stroke: An encephalopathy induced by angiitis induced by angiitis after vascular thrombosis in patients with acute ischemic stroke
Time of Update: 2020-11-04
of the 421 patients with acute ischemic stroke who received EVT, 7 (1.7%) had CIE, which included increased symptoms of the regenerative nervous system, coma and seizures.
